Investment & Fund Management
European Investment Fund Partner
Full Credential Description
NeuroNation, a Berlin-based company, addresses the growing challenge of cognitive impairment, particularly in the context of an ageing population and the rising incidence of Alzheimers disease. Co-founder Jakob Futorjanski highlighted the urgency of the issue, noting that many individuals, including his own family members, are affected by cognitive decline. The company developed a digital cognitive training program aimed at improving memory, attention span, and overall cognitive fitness. This program is particularly beneficial for patients recovering from strokes, brain injuries, and age-related cognitive disorders, where traditional rehabilitation can involve long waiting times and high costs.
The tailored solution provided by NeuroNation includes a fully digital platform that offers personalized cognitive training based on individual cognitive profiles. Users engage in daily challenges and games designed to make the training enjoyable and effective, all from the comfort of their homes. This innovative approach not only enhances accessibility but also addresses the pressing need for timely cognitive rehabilitation.
The impact of NeuroNation's program is quantifiable. As of now, 68,000 users have engaged in cognitive training for 10 hours or more upon recommendation from healthcare professionals, with 28,000 of those users participating in 2020 alone. The company received investment from Impact Partners, which facilitated the clinical validation of their application and helped establish social impact performance indicators to monitor user improvement. With a user base of 20 million worldwide, NeuroNation is making significant strides in combating cognitive decline and improving the quality of life for individuals affected by cognitive impairments.